A Study to Evaluate the Effects of continuous Versus Premixed Administration of Hyperbaric Ropivacaine 0.75% and Fentanyl in patients planned for Elective Urological Surgery Under Spinal Anaesthesia

A Randomized Comparative Study to Evaluate the Effects of Successional Versus Premixed Administration of Intrathecal Hyperbaric Ropivacaine 0.75% and Fentanyl in patients scheduled for Elective Urological Surgery Under Spinal Anaesthesia - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063018

Enrollment

Registered

2024-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Premixed Spinal Anaesthesia: Group P: premixed 0.75% hyperbaric ropivacaine 2.5ml and 0.5ml of fentanyl in a single 5.0ml syringe Control Intervention1: Successional administration of

Eligibility

Inclusion criteria

Inclusion criteria: either gender of age 18-55years and ASA I and ASA II status scheduled for elective urological surgery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: 1. Negative consent by the patient 2. contraindication for spinal anaesthesia ( such as coagulopathy, infection at injection site, hypotension ,disease or deformity of spine) 3.psychiatric patient 4. ASA status III/IV 5. known sensitivity to drug

Design outcomes

Primary

Measure	Time frame
To study the onset ,duration and highest level of sensory block along with degree and duration of motor blockTimepoint: intraoperative period after spinal anaesthesia	—

Secondary

Measure	Time frame
To study the hemodynamic changes occuring among the two study groups after administration of the respective drugs To study the side effectsTimepoint: intraoperative period after spinal anaesthesia	—

Countries

India

Contacts

Public ContactSapna Bansal

MM Institute of Medical Sciences and Research

drsapna10@gmail.com8168381441

Outcome results